Neural networks are a relatively new method of multivariate analysis. The purpose of this study was to investigate the ability of neural networks to differentiate benign from malignant breast conditions on the basis of the pattern of nine variables: patient age, total cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A-I, apolipoprotein B, albumin, the tumor marker CAl 5-3, and the Fossel index (measurement of methylene and methyl line-widths in proton NMR spectra). The laboratory analyses were made with blood plasma or serum specimens. The neural network was "trained" with 57 patients: 23 patients with breast malignancies and 34 patients with benign breast conditions. A neural network with nine input neurons, 15 hidden neurons, and two output neurons correctly classified all 57 patients. The ability of the network to predict the diagnoses of patients that it had not encountered in training was tested with a separate group (cross-validation group) of 20 patients. The network correctly predicted the diagnoses for 80% of these patients. For comparison we analyzed the same sets of 57 training patients and 20 cross-validation patients by quadratic discriminantfunction analysis. The quadratic discriminant function, calculated from the same 57 patients used to train the neural network, correctly classified 84% of the 57 patients, and correctly diagnosed 75% of the 20 crossvalidation patients. The results suggest that neural networks are a potentially useful multivariate method for optimizing the diagnostic utility of laboratory data. The data were collected from women undergoing investigation for breast cancer. We included the following nine variables in our analysis: patient age, total cholesterol, high-density lipoprotein (HDL)-cholesterol, One of the rationales for choosing these nine variables was their association with malignancy. Previous work from our laboratory (10) as well as that from others (9, 11) has established that changes in various 
(DFA) (1__5).2
Neural networks are a relatively new, radically different approach to the interpretation of multivariate data (see description below). Over the last few years, neural network software has become readily available, and the networks have grown in popularity.
Recently, this approach has been explored for its value in clinical diagnosis in psychiatry (6) and pediatric radiology (7, 8 The data were collected from women undergoing investigation for breast cancer. We included the following nine variables in our analysis: patient age, total cholesterol, high-density lipoprotein (HDL)-cholesterol,
triglycerides, apolipoprotein
A-I, apolipoprotein B, albumin, antigen CA15-3, and the Fossel index [measurement of methylene and methyl line-widths in proton nuclear magnetic resonance (NMR) spectra, as described by Fossel et al. (9) ]. The laboratory analyses were performed with specimens of blood plasma or serum.
One of the rationales for choosing these nine variables was their association with malignancy. Previous work from our laboratory (10) as well as that from others (9, 11) has established that changes in various PA) (13) .
Neural Networks
Neural networks were constructed by using version 2.0 of the "Brainmaker Every input neuron is connected to every hidden neuron, and every hidden neuron is connected to every output neuron. Each of the multiple connections to a particular neuron is weighted. A neuron fires if the sum of the weighted inputs to it are greater than a threshold value. Once a neuron is above threshold, the magnitude One input neuron is assigned for each input variable (predictor variable). For our data, there are nine input neurons: one to represent each of eight laboratory measurements and one to represent the patient's age. The user chooses the number of hidden neurons. In practice, the optimal number of hidden neurons is determined empirically. One output neuron is assigned for each output category. Our network has two output neurons, one for each of two possible diagnoses. Ideally, a malignancy is represented by maximal output of the "malignant" output neuron and silence of the "benign" neuron, whereas a benign process is represented by maximal output of the "benign" neuron and silence of the "malignant" neuron. is the error tolerance, which specifies how close the estimated output has to be to the actual output to be considered correct. For the network presented below, the training tolerance was set at 5%.
That is, the estimate of a malignancy was considered correct if the malignant output neuron fired at >95% of maximum and the benign neuron fired at <5% of maximum (the sum of the activity of the two output neurons is always 100%). Similarly, a correct estimate of a benign condition meant that the benign output neuron fired at >95% of maximum and the malignant neuron fired at <5% of maximum.
We trained many neural networks. These networks differed in their training tolerances, in the number of hidden neurons they contained, and in the values of several other adjustable training parameters. Our goal was to systematically vary the hidden neurons and the other training parameters to optimize the behavior of the network. The network that was most successful at classifying the training group and predicting the results for the cross-validation group is presented below. This network was completely trained after 697 presentations of the training group, which required 1 h and 54 mm on the microcomputer (processor speed, 4.77 MHz). Figure  2 shows the learning curve for this network. The performance of the network gradually improved as the set of 57 patients was repeatedly presented. study, a relatively new approach to the interpretation of 1650(320) laboratory data, neural networks, was used to separate 1160(360) patients into diagnostic categories based on subtle pat- 44(6) terns in laboratory data. 
Discriminant Function Analysis

DFA was performed with the Statistical Analysis
Results
Data summary.
A summary of the predictor variables is presented in Table 1 . There were significant differences between the benign and malignant groups with respect to mean HDL-cholesterol (P <0.05, Student's t-test) and CA15-3 (P <0.05). The other seven predictor variables did not differ significantly between the two diagnostic groups. None of the nine variables, including the two that showed significant differences between diagnoses, were useful as individual clinical tests for distinguishing breast malignancy from benign breast conditions.
Data classification. The results of the classification by a neural network and QDFA are presented in Table 2 . The neural network contained nine input neurons, 15 hidden neurons, and two output neurons. This network correctly classified all 57 patients in the training group at an error tolerance of 5%. The quadratic discriminant function (incorporating seven of the nine predictor variables) correctly classified 84% of the same 57 patients. The success rates for the individual diagnostic categories were 78% for the malignant breast masses and 88% for the benign conditions.
Cross validation.
A group of 20 patients with known diagnoses (10 with benign breast lesions and 10 with breast malignancies) were used for cross validation. These patients were excluded from the group of 57 patients who were used to train the neural network and compute the discriminant function.
The results are presented in 
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